Charles River Laboratories (CRL) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Charles River Laboratories Revenue Highlights

Latest Revenue (Y)

$4.02B

Latest Revenue (Q)

$995.83M

Main Segment (Y)

Discovery and Safety Assessment

Main Geography (Y)

UNITED STATES

Charles River Laboratories Revenue by Period

Charles River Laboratories Revenue by Year

Date	Revenue	Change
2025-12-27	$4.02B	-0.85%
2024-12-28	$4.05B	-1.92%
2023-12-31	$4.13B	3.86%
2022-12-31	$3.98B	12.31%
2021-12-31	$3.54B	21.08%
2020-12-31	$2.92B	11.55%
2019-12-31	$2.62B	15.67%
2018-12-31	$2.27B	21.99%
2017-12-31	$1.86B	10.48%
2016-12-31	$1.68B	23.34%
2015-12-31	$1.36B	5.06%
2014-12-31	$1.30B	11.34%
2013-12-31	$1.17B	3.19%
2012-12-31	$1.13B	-1.15%
2011-12-31	$1.14B	0.81%
2010-12-31	$1.13B	-5.75%
2009-12-31	$1.20B	-10.49%
2008-12-31	$1.34B	9.17%
2007-12-31	$1.23B	16.27%
2006-12-31	$1.06B	-5.69%
2005-12-31	$1.12B	46.33%
2004-12-31	$766.92M	24.96%
2003-12-31	$613.72M	10.65%
2002-12-31	$554.63M	19.11%
2001-12-31	$465.63M	51.88%
2000-12-31	$306.58M	39.82%
1999-12-31	$219.28M	13.44%
1998-12-31	$193.30M	-

Charles River Laboratories generated $4.02B in revenue during NA 2025, up -0.85% compared to the previous quarter, and up 137.33% compared to the same period a year ago.

Charles River Laboratories Revenue by Quarter

Date	Revenue	Change
2026-03-28	$995.83M	0.16%
2025-12-27	$994.23M	-1.06%
2025-09-27	$1.00B	-2.64%
2025-06-28	$1.03B	4.87%
2025-03-29	$984.17M	-1.83%
2024-12-31	$1.00B	-0.71%
2024-09-28	$1.01B	-1.59%
2024-06-29	$1.03B	1.44%
2024-03-30	$1.01B	-0.19%
2023-12-31	$1.01B	-1.28%
2023-09-30	$1.03B	-3.14%
2023-07-01	$1.06B	2.97%
2023-04-01	$1.03B	-6.41%
2022-12-31	$1.10B	11.19%
2022-09-24	$989.16M	1.65%
2022-06-25	$973.13M	6.48%
2022-03-26	$913.93M	0.98%
2021-12-31	$905.05M	1.02%
2021-09-25	$895.94M	-2.04%
2021-06-26	$914.61M	10.92%
2021-03-27	$824.57M	4.24%
2020-12-31	$790.99M	6.42%
2020-09-26	$743.30M	8.90%
2020-06-27	$682.58M	-3.46%
2020-03-28	$707.06M	2.30%
2019-12-31	$691.14M	3.47%
2019-09-28	$667.95M	1.58%
2019-06-29	$657.57M	8.77%
2019-03-30	$604.57M	0.51%
2018-12-31	$601.53M	2.77%
2018-09-29	$585.29M	-0.00%
2018-06-30	$585.30M	18.49%
2018-03-31	$493.97M	3.24%
2017-12-30	$478.48M	3.07%
2017-09-30	$464.23M	-1.04%
2017-07-01	$469.13M	5.24%
2017-04-01	$445.76M	-4.50%
2016-12-31	$466.79M	9.65%
2016-09-24	$425.72M	-1.92%
2016-06-25	$434.06M	22.31%
2016-03-26	$354.87M	0.29%
2015-12-26	$353.85M	1.25%
2015-09-26	$349.46M	2.91%
2015-06-27	$339.57M	5.98%
2015-03-28	$320.41M	-2.77%
2014-12-27	$329.55M	0.60%
2014-09-27	$327.57M	-3.99%
2014-06-28	$341.18M	13.97%
2014-03-29	$299.37M	3.51%
2013-12-28	$289.23M	-0.99%
2013-09-28	$292.13M	-0.27%
2013-06-29	$292.93M	0.58%
2013-03-30	$291.24M	3.96%
2012-12-29	$280.14M	0.52%
2012-09-29	$278.69M	-2.12%
2012-06-30	$284.72M	-0.44%
2012-03-31	$285.98M	-1.71%
2011-12-31	$290.96M	4.82%
2011-09-24	$277.58M	-3.71%
2011-06-25	$288.26M	0.85%
2011-03-26	$285.84M	6.70%
2010-12-25	$267.89M	-2.97%
2010-09-25	$276.08M	-5.49%
2010-06-26	$292.10M	-1.76%
2010-03-27	$297.35M	0.66%
2009-12-26	$295.38M	-0.71%
2009-09-26	$297.49M	-3.46%
2009-06-27	$308.16M	2.20%
2009-03-28	$301.53M	-3.19%
2008-12-27	$311.45M	-8.99%
2008-09-27	$342.23M	-2.81%
2008-06-28	$352.13M	4.28%
2008-03-29	$337.69M	6.18%
2007-12-29	$318.03M	-

Charles River Laboratories generated $995.83M in revenue during Q1 2026, up 0.16% compared to the previous quarter, and up 99.33% compared to the same period a year ago.

Charles River Laboratories Revenue Breakdown

Charles River Laboratories Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Research Models and Services	$846.08M	$829.38M	$792.34M	-	-
Discovery and Safety Assessment	$2.40B	$2.45B	$2.62B	-	-
Manufacturing Support	$766.41M	$769.33M	$721.44M	-	-
Product	-	-	$689.39M	$759.16M	$784.58M
Service	-	-	$3.44B	$3.22B	$2.76B

Charles River Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 25: Discovery and Safety Assessment (59.84%), Research Models and Services (21.07%), and Manufacturing Support (19.09%).

Quarterly Revenue by Product

Product/Service	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jul 23	Apr 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Research Models and Services	$208.37M	$206.26M	$213.47M	$213.27M	$213.07M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discovery and Safety Assessment	$596.92M	$591.57M	$600.68M	$618.03M	$592.61M	$1.23B	$615.06M	$605.45M	-	-	-	-	-	-	-	-	-	-	-	-
Manufacturing Support	$190.54M	$196.40M	$190.69M	$200.84M	$178.49M	$387.25M	$196.88M	$185.20M	-	-	-	-	-	-	-	-	-	-	-	-
Product	-	-	-	-	-	-	-	$194.70M	$175.47M	$156.86M	$185.05M	$172.01M	$199.15M	$176.26M	$190.30M	$193.44M	$195.23M	$192.08M	$199.29M	$197.99M
Service	-	-	-	-	-	-	-	$816.86M	$838.00M	$869.76M	$874.89M	$857.37M	$900.70M	$812.89M	$782.83M	$720.49M	$709.82M	$703.86M	$715.32M	$626.58M

Charles River Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Discovery and Safety Assessment (59.94%), Research Models and Services (20.92%), and Manufacturing Support (19.13%).

Charles River Laboratories Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
UNITED STATES	$2.14B	$2.24B	$2.35B	$2.34B	$1.93B
Asia Pacific	$205.02M	$196.95M	$200.83M	$192.84M	$222.90M
CANADA	$501.02M	$482.09M	$487.31M	$398.98M	$339.10M
Europe	$1.10B	$1.08B	$1.08B	$1.03B	$1.04B
Other	-	-	$16.85M	$9.96M	$7.29M

Charles River Laboratories's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (54.22%), Europe (27.91%), CANADA (12.68%), and Asia Pacific (5.19%).

Quarterly Revenue by Country

Country	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jul 23	Apr 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
UNITED STATES	$543.81M	$517.35M	$537.61M	$549.86M	$536.96M	$1.12B	$559.28M	$562.32M	$544.95M	$590.32M	$606.77M	$605.44M	$653.43M	$595.26M	$566.92M	$526.55M	$500.74M	$493.56M	$491.62M	$448.48M
CANADA	$109.57M	$123.28M	$116.81M	$135.59M	$125.35M	$244.60M	$127.09M	$110.40M	$130.03M	$129.02M	$117.65M	$110.61M	$118.44M	$101.60M	$93.69M	$85.25M	$86.17M	$85.25M	$90.56M	$77.11M
Europe	$277.58M	$279.90M	$277.69M	$281.86M	$263.25M	$534.70M	$267.12M	$276.32M	$271.47M	$264.79M	$272.98M	$267.70M	$271.53M	$245.93M	$263.58M	$251.09M	$264.87M	$258.35M	$275.71M	$237.53M
Asia Pacific	$55.48M	$56.91M	$51.66M	$54.50M	$41.94M	$106.17M	$45.01M	$45.77M	$57.92M	$40.23M	$59.86M	$42.81M	$53.85M	$43.80M	$46.24M	$48.95M	$51.72M	$56.61M	$55.13M	$59.45M
Other	-	-	-	-	-	-	-	$16.75M	$9.10M	$2.26M	$2.67M	$2.81M	$2.60M	$2.56M	$2.70M	$2.10M	$1.55M	$2.16M	$1.58M	$2.00M

Charles River Laboratories's latest quarterly revenue breakdown by geography, as of Mar 26: UNITED STATES (55.13%), Europe (28.14%), CANADA (11.11%), and Asia Pacific (5.62%).

Charles River Laboratories Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
DVA	DaVita	$13.64B	$3.42B
CRL	Charles River Laboratories	$4.02B	$995.83M
RVTY	Revvity	$2.86B	$711.12M
BIO	Bio-Rad Laboratories	$2.58B	$592.10M
QGEN	Qiagen	$1.97B	$458.80M
PEN	Penumbra	$1.40B	$354.69M
BAX	Baxter	$352.00M	$2.70B
CAI	Caris Life Sciences	$294.01M	$216.17M
RNA	Atrium Therapeutics	$18.75M	$12.47M
AVTR	Avantor	-	-

CRL Revenue FAQ

What is Charles River Laboratories’s yearly revenue?

Charles River Laboratories's yearly revenue for 2025 was $4.02B, representing a decrease of -0.85% compared to 2024. The company's yearly revenue for 2024 was $4.05B, representing a decrease of -1.92% compared to 2023. CRL's yearly revenue for 2023 was $4.13B, representing an increase of 3.86% compared to 2022.

What is Charles River Laboratories’s quarterly revenue?

Charles River Laboratories's quarterly revenue for Q1 2026 was $995.83M, a 0.16% increase from the previous quarter (Q4 2025), and a 1.18% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $994.23M, a -1.06% decrease from the previous quarter (Q3 2025), and a -0.83% decrease year-over-year (Q4 2024). CRL's quarterly revenue for Q3 2025 was $1B, a -2.64% decrease from the previous quarter (Q2 2025), and a -0.49% decrease year-over-year (Q3 2024).

What is Charles River Laboratories’s revenue growth rate?

Charles River Laboratories's revenue growth rate for the last 3 years (2023-2025) was -2.76%, and for the last 5 years (2021-2025) was 13.42%.

What are Charles River Laboratories’s revenue streams?

Charles River Laboratories's revenue streams in c 25 are Research Models and Services, Discovery and Safety Assessment, and Manufacturing Support. Research Models and Services generated $846.08M in revenue, accounting 21.07% of the company's total revenue, up 2.01% year-over-year. Discovery and Safety Assessment generated $2.4B in revenue, accounting 59.84% of the company's total revenue, down -1.97% year-over-year. Manufacturing Support generated $766.41M in revenue, accounting 19.09% of the company's total revenue, down -0.38% year-over-year.

What is Charles River Laboratories’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Charles River Laboratories was Discovery and Safety Assessment. This segment made a revenue of $2.4B, representing 59.84% of the company's total revenue.